Pentao Liu, Professor of The Wellcome Trust Sanger Institute, Cambridge, U.K. Dr. Liu graduated from Henan Normal University and earned his Master of Science degree from Chinese Academy of Sciences/University of Science and Technology of China.At Baylor College of Medicine, he studied molecular mechanisms of Charcoal-Marie-Tooth disease in Dr James Lupski's laboratory. Dr. Liu received his PhD from Baylor College of Medicine under the guidance of Professor Allan Bradley, and completed his postdoctoral training at National Cancer Institute (USA) in the laboratories of Dr. Neal Copeland and Dr. Nancy Jenkins.Dr. Liu joined the Wellcome Trust Sanger Institute in September 2003. He initiated the high-throughput recombineering for the large-scale mouse mutagenesis programme at the Sanger Institute. Dr. Liu's laboratory has identified the critical roles of transcription factors, Bcl11a and Bcl11b, in hematopoietic stem cells, in lymphocyte development, and in mammary gland development. By mutating Bcl11b, they have discovered that T lymphocytes are reprogrammed to a new type of cancer killer cells, ITNKs. Dr. Liu's lab has also identified that BCL11A is an important cancer gene in triple negative breast cancer.
我们专注于根据您的具体需求（包括演讲议题、会议日期及活动预算等），为您精准匹配各领域专业嘉宾。为高效服务，建议您提前准备好详细活动信息，并拨打客服电话：18911802888（工作日9:00-18:00）。
温馨提示：本服务仅限嘉宾邀约相关事宜，其他需求暂不处理，感谢您的理解与配合。